Sharps Technology (STSS) vs. Its Competitors: A Critical Review
When comparing Sharps Technology (STSS) to its competitors in the medical device sector, several key financial indicators and ownership statistics shed light on its performance and potential.
Profitability
In terms of profitability, we can analyze net margins, return on equity, and return on assets.
| | Net Margins | Return on Equity | Return on Assets |
|——————————|————-|——————|——————|
| Sharps Technology | N/A | -102.25% | -72.97% |
| Sharps Technology Competitors| -627.86% | -133.35% | -27.87% |
Examples: If you were to invest $100 in Sharps Technology, -102.25% return on equity means you might lose around $102.25.
Institutional and Insider Ownership
Ownership by large institutional investors and company insiders is an indicator of confidence in a company's future.
- Sharps Technology: 17.2% owned by institutional investors, 14.1% by insiders.
- Competitors: 48.5% owned by institutional investors, 15.2% by insiders.
Volatility and Risk
Volatility measures how much a stock's price fluctuates. A beta value greater than 1 means more volatility.
- Sharps Technology: Beta of 1.36 (36% more volatile than the market)
- Competitors: Beta of 0.58 (42% less volatile than the market)
Examples: High volatility might mean bigger ups and downs in Sharps Technology's stock price, which can be risky for some investors.
Analyst Ratings
Analysts give ratings to help investors understand a stock's potential growth.
| | Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score |
|——————————|————–|————–|————-|——————-|————–|
| Sharps Technology | 0 | 0 | 0 | 0 | N/A |
| Sharps Technology Competitors| 1673 | 4453 | 8636 | 232 | 2.50 |
Valuation and Earnings
We can look at gross revenue, net income, and valuation to assess value for money.
| | Gross Revenue | Net Income | Price/Earnings Ratio |
|——————————|—————|—————|———————-|
| Sharps Technology | N/A | -$9.84 million| -0.45 |
| Competitors | $1.03 billion | $3.54 million | -4,470.40 |
Summary
Sharps Technology's competitors outperformed Sharps Technology in 6 out of 9 factors analyzed. This includes profitability, investor confidence, volatility, analyst ratings, and valuation metrics.
Sharps Technology Company Profile
Sharps Technology, Inc., based in Melville, New York, specializes in developing safety syringe products such as the Sharps Provensa. It focuses on reducing waste when administering vaccines and medications.
Conclusion
While Sharps Technology is working hard in the field of medical devices, its competitors currently exhibit stronger performance across multiple metrics. For those considering investment, understanding these indicators is crucial.
Note: The above information is based on current data and may change. Always consult with a financial advisor before making investment decisions.
